Perbedaan Kalbe Farma Tbk dan Phapros Tbk.: Kalbe Farma Tbk diperdagangkan di Rp720 (kapitalisasi pasar 33 T, volume 24 jam 98,44 jt), sedangkan Phapros Tbk. diperdagangkan di Rp258 (kapitalisasi pasar 215,04 M, volume 24 jam 158,1 rb). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 153,5× kapitalisasi pasar Phapros Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (98,44 jt vs 158,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | PEHA | |
|---|---|---|
Kapitalisasi Pasar | 33 T | 215,04 M |
Volume | 98,44 jt | 158,1 rb |
Lot | 984,38 rb | 1,58 rb |
Perputaran | 70,64 M | 40,83 jt |
Harga Rata-rata | 717,58 | 258,26 |
Nilai Transaksi | 70,64 M | 40,83 jt |
Harga Ekuilibrium Indikatif | 720 | 258 |
Volume Ekuilibrium Indikatif | 43,62 rb | 10 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Selengkapnya di halaman PEHA →